Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Recommendations of the National Heart, Lung, and Blood Institute Nanotechnology Working Group.

Buxton DB, Lee SC, Wickline SA, Ferrari M; National Heart, Lung, and Blood Institute Nanotechnology Working Group..

Circulation. 2003 Dec 2;108(22):2737-42.

2.

National Heart, Lung, and Blood Institute and the translation of cardiovascular discoveries into therapeutic approaches.

Galis ZS, Black JB, Skarlatos SI.

Circ Res. 2013 Apr 26;112(9):1212-8. doi: 10.1161/CIRCRESAHA.113.301100.

3.

Nanotechnology research support at the National Heart, Lung, and Blood Institute.

Buxton DB.

Circ Res. 2011 Jul 22;109(3):250-4. doi: 10.1161/RES.0b013e31822a97cd. No abstract available.

4.

Cardiovascular tissue engineering research support at the National Heart, Lung, and Blood Institute.

Lundberg MS.

Circ Res. 2013 Apr 12;112(8):1097-103. doi: 10.1161/CIRCRESAHA.112.300638. Review.

5.

Report of the National Heart, Lung, and Blood Institute working group on outcomes research in cardiovascular disease.

Krumholz HM, Peterson ED, Ayanian JZ, Chin MH, DeBusk RF, Goldman L, Kiefe CI, Powe NR, Rumsfeld JS, Spertus JA, Weintraub WS; National Heart, Lung, and Blood Institute working group..

Circulation. 2005 Jun 14;111(23):3158-66.

6.

Centers for cardiovascular outcomes research: defining a collaborative vision.

Cook NL, Bonds DE, Kiefe CI, Curtis JP, Krumholz HM, Kressin NR, Peterson ED; National Heart, Lung, and Blood Institute Centers for Cardiovascular Research (CCOR) Writing Group..

Circ Cardiovasc Qual Outcomes. 2013 Mar 1;6(2):223-8. doi: 10.1161/CIRCOUTCOMES.0b013e31828e8d5c. Epub 2013 Mar 12.

7.

Nanotechnology: an evidence-based analysis.

Health Quality Ontario..

Ont Health Technol Assess Ser. 2006;6(19):1-43. Epub 2006 Nov 1.

8.

Stimulating high impact HIV-related cardiovascular research: recommendations from a multidisciplinary NHLBI Working Group on HIV-related heart, lung, and blood disease.

Shah MR, Cook N, Wong R, Hsue P, Ridker P, Currier J, Shurin S.

J Am Coll Cardiol. 2015 Feb 24;65(7):738-44. doi: 10.1016/j.jacc.2014.12.014. Review.

9.

Strategic transformation of population studies: recommendations of the working group on epidemiology and population sciences from the National Heart, Lung, and Blood Advisory Council and Board of External Experts.

Roger VL, Boerwinkle E, Crapo JD, Douglas PS, Epstein JA, Granger CB, Greenland P, Kohane I, Psaty BM.

Am J Epidemiol. 2015 Mar 15;181(6):363-8. doi: 10.1093/aje/kwv011. Epub 2015 Mar 4.

10.

Ethical and practical guidelines for reporting genetic research results to study participants: updated guidelines from a National Heart, Lung, and Blood Institute working group.

National Heart, Lung, and Blood Institute working group., Fabsitz RR, McGuire A, Sharp RR, Puggal M, Beskow LM, Biesecker LG, Bookman E, Burke W, Burchard EG, Church G, Clayton EW, Eckfeldt JH, Fernandez CV, Fisher R, Fullerton SM, Gabriel S, Gachupin F, James C, Jarvik GP, Kittles R, Leib JR, O'Donnell C, O'Rourke PP, Rodriguez LL, Schully SD, Shuldiner AR, Sze RK, Thakuria JV, Wolf SM, Burke GL.

Circ Cardiovasc Genet. 2010 Dec;3(6):574-80. doi: 10.1161/CIRCGENETICS.110.958827.

11.

Recommendations of the National Heart, Lung, and Blood Institute Heart and Lung Xenotransplantation Working Group.

Platt J, DiSesa V, Gail D, Massicot-Fisher J; National Heart, Lung, and Blood Institute Heart and Lung Xenotransplantation Working Group..

Circulation. 2002 Aug 27;106(9):1043-7.

12.
13.

Summary of NIH Medical-Surgical Emergency Research Roundtable held on April 30 to May 1, 2009.

Kaji AH, Lewis RJ, Beavers-May T, Berg R, Bulger E, Cairns C, Callaway C, Camargo CA Jr, Carcillo J, DeBiasi R, Diaz T, Ducharme F, Glickman S, Heilpern K, Hickey R, Hoek TV, Hollander J, Janson S, Jurkovich G, Kellermann A, Kingsmore S, Kline J, Kuppermann N, Lowe R, McLario D, Nathanson L, Nichol G, Peitzman A, Richardson L, Sanders A, Shah M, Shapiro N, Silverman R, Than M, Wilber S, Yealy DM; Roundtable External Participants and Roundtable Steering Committee and Federal Participants..

Ann Emerg Med. 2010 Nov;56(5):522-37. doi: 10.1016/j.annemergmed.2010.03.014.

PMID:
21036293
14.

The present and future of nanotechnology in human health care.

Sahoo SK, Parveen S, Panda JJ.

Nanomedicine. 2007 Mar;3(1):20-31. Review.

PMID:
17379166
15.

Nanotech approaches to drug delivery and imaging.

Sahoo SK, Labhasetwar V.

Drug Discov Today. 2003 Dec 15;8(24):1112-20. Review.

PMID:
14678737
16.

Applications of carbon nanotubes-based biomaterials in biomedical nanotechnology.

Polizu S, Savadogo O, Poulin P, Yahia L.

J Nanosci Nanotechnol. 2006 Jul;6(7):1883-904. Review.

PMID:
17025102
17.

National Heart, Lung, And Blood Institute Clinical Proteomics Working Group report.

Granger CB, Van Eyk JE, Mockrin SC, Anderson NL; National Heart, Lung, And Blood Institute Clinical Proteomics Working Group..

Circulation. 2004 Apr 13;109(14):1697-703.

18.

Report of the National Heart, Lung, and Blood Institute Working Group on Sex Differences Research in Cardiovascular Disease: Scientific Questions and Challenges.

Maric-Bilkan C, Arnold AP, Taylor DA, Dwinell M, Howlett SE, Wenger N, Reckelhoff JF, Sandberg K, Churchill G, Levin E, Lundberg MS.

Hypertension. 2016 May;67(5):802-7. doi: 10.1161/HYPERTENSIONAHA.115.06967. Epub 2016 Mar 14. Review. No abstract available.

19.

Nanomedicine in cardiovascular therapy: recent advancements.

Binsalamah ZM, Paul A, Prakash S, Shum-Tim D.

Expert Rev Cardiovasc Ther. 2012 Jun;10(6):805-15. doi: 10.1586/erc.12.41. Review.

PMID:
22894635
20.

Nanotechnology applications in medicine and dentistry.

Gupta J.

J Investig Clin Dent. 2011 May;2(2):81-8. doi: 10.1111/j.2041-1626.2011.00046.x. Epub 2011 Feb 17. Review.

PMID:
25426600

Supplemental Content

Support Center